Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan
· Delayed Price · Currency is TWD 21.15
0.00 (0.00%)
May 16, 2025, 10:07 AM CST
Bioray Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Net Income | 1 | -11.56 | 0.5 | -7.19 | -0.06 | Upgrade
|
| Depreciation & Amortization | 24.98 | 24.48 | 21.87 | 18.83 | 15.21 | Upgrade
|
| Other Amortization | - | 0.52 | 0.36 | 0.25 | 0.07 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.2 | -0.18 | - | 3.06 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 1.3 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.05 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | - | - | 0.02 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 0.44 | -0.01 | 0.08 | - | 0.31 | Upgrade
|
| Other Operating Activities | 1.79 | -0.27 | 1.8 | 1.62 | -8.21 | Upgrade
|
| Change in Accounts Receivable | -4.2 | -0.56 | -5.96 | -13.66 | 7.87 | Upgrade
|
| Change in Inventory | 9.18 | -4.12 | -6.44 | 2.82 | -12.62 | Upgrade
|
| Change in Accounts Payable | -4.96 | -3.15 | 1.21 | 4.75 | -0.42 | Upgrade
|
| Change in Unearned Revenue | 4.97 | -2.52 | -2.98 | 1.49 | -2.34 | Upgrade
|
| Change in Other Net Operating Assets | -16.6 | -4.67 | -7.8 | -0.07 | -1.19 | Upgrade
|
| Operating Cash Flow | 16.65 | -0.76 | 2.48 | 8.83 | 1.67 | Upgrade
|
| Operating Cash Flow Growth | - | - | -71.93% | 427.42% | -97.31% | Upgrade
|
| Capital Expenditures | -3.22 | -10.02 | -59.64 | -14.98 | -51 | Upgrade
|
| Sale of Property, Plant & Equipment | 50.56 | 0.2 | 0.36 | 0.55 | 0.08 | Upgrade
|
| Cash Acquisitions | - | -3.54 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.08 | -0.16 | -0.75 | -0.56 | -0.38 | Upgrade
|
| Other Investing Activities | 6.46 | 0.97 | 0.39 | -4.8 | -1.6 | Upgrade
|
| Investing Cash Flow | 53.72 | -12.55 | -59.63 | -19.79 | -52.9 | Upgrade
|
| Short-Term Debt Issued | 55 | 10 | 15 | 15 | - | Upgrade
|
| Total Debt Issued | 55 | 10 | 15 | 15 | - | Upgrade
|
| Short-Term Debt Repaid | -20 | -25 | -25 | -17.2 | - | Upgrade
|
| Long-Term Debt Repaid | -9.7 | -7.59 | -6.42 | -5.95 | -6.08 | Upgrade
|
| Total Debt Repaid | -29.7 | -32.59 | -31.42 | -23.15 | -6.08 | Upgrade
|
| Net Debt Issued (Repaid) | 25.3 | -22.59 | -16.42 | -8.15 | -6.08 | Upgrade
|
| Common Dividends Paid | - | -6.02 | - | - | -8.02 | Upgrade
|
| Other Financing Activities | -14.49 | -0.13 | 86.34 | -0.48 | -1.23 | Upgrade
|
| Financing Cash Flow | 10.82 | -28.73 | 69.92 | -8.64 | -15.33 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0 | -0.01 | 0.01 | -0.5 | Upgrade
|
| Net Cash Flow | 81.19 | -42.04 | 12.75 | -19.59 | -67.05 | Upgrade
|
| Free Cash Flow | 13.43 | -10.78 | -57.16 | -6.15 | -49.32 | Upgrade
|
| Free Cash Flow Margin | 6.66% | -5.62% | -29.99% | -4.15% | -31.56% | Upgrade
|
| Free Cash Flow Per Share | 0.40 | -0.36 | -2.04 | -0.23 | -1.84 | Upgrade
|
| Cash Interest Paid | - | 0.13 | 0.33 | 0.95 | 1.17 | Upgrade
|
| Cash Income Tax Paid | - | 0.03 | -1.17 | 0.36 | 7.99 | Upgrade
|
| Levered Free Cash Flow | 7.72 | -12.81 | -60.67 | -5.78 | -54.3 | Upgrade
|
| Unlevered Free Cash Flow | 8.55 | -11.98 | -59.81 | -5.18 | -53.57 | Upgrade
|
| Change in Net Working Capital | 10.43 | 14.72 | 21.48 | 3.66 | 17.34 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.